4.5 Article

Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021

Mary B. Daly et al.

Summary: The NCCN Guidelines focus on assessing genetic variants associated with increased risk of breast, ovarian, and pancreatic cancer, particularly BRCA-related breast/ovarian cancer syndrome and Li-Fraumeni syndrome. Individuals with pathogenic BRCA1/2 variants have high risks of breast and ovarian cancer, as well as elevated risks of prostate cancer and pancreatic cancer. Li-Fraumeni syndrome is associated with high lifetime risks of various cancers.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

Article Oncology

Canada follows the US in the rise of bilateral mastectomies for unilateral breast cancer: a 23-year population cohort study

L. Findlay-Shirras et al.

Summary: This study examined trends in mastectomy rates for UBC patients in Ontario from 1991 to 2013, finding a sixfold increase in BM rates across all age groups under 70. Factors associated with increased odds of BM included younger age, higher income, rural community, earlier breast cancer stage, lobular histology, availability of reconstruction, and treatment at a teaching hospital.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Article Oncology

Management of Male Breast Cancer: ASCO Guideline

Michael J. Hassett et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Review Oncology

Male breast cancer: a disease distinct from female breast cancer

Ayca Gucalp et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

Article Oncology

Molecular Characterization and Mortality From Breast Cancer in Men

Suleiman Alfred Massarweh et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Review Medicine, General & Internal

Breast Cancer in Men

Sharon H. Giordano

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Meeting Abstract Oncology

Adjuvant tamoxifen adherence in men with early stage breast cancer.

Oluchi Oke et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Article Oncology

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results

Mary Pritzlaff et al.

BREAST CANCER RESEARCH AND TREATMENT (2017)

Article Oncology

Familial associations of female breast cancer with other cancers

Guoqiao Zheng et al.

INTERNATIONAL JOURNAL OF CANCER (2017)

Article Medicine, General & Internal

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Karoline B. Kuchenbaecker et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Review Cell Biology

The cancer genetics and pathology of male breast cancer

Siddhartha Deb et al.

HISTOPATHOLOGY (2016)

Article Oncology

Outcome of Male Breast Cancer: A Matched Single-Institution Series

Monica Iorfida et al.

CLINICAL BREAST CANCER (2014)

Editorial Material Medicine, General & Internal

Contralateral Prophylactic Mastectomy Is It a Reasonable Option?

Lisa A. Newman

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Article Oncology

Survival Outcomes After Contralateral Prophylactic Mastectomy: A Decision Analysis

Pamela R. Portschy et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)

Review Oncology

Contralateral risk-reducing mastectomy in sporadic breast cancer

John A. Murphy et al.

LANCET ONCOLOGY (2013)

Article Oncology

Tamoxifen adherence and its relationship to mortality in 116 men with breast cancer

Shouping Xu et al.

BREAST CANCER RESEARCH AND TREATMENT (2012)

Article Oncology

Declining Incidence of Contralateral Breast Cancer in the United States From 1975 to 2006

Hazel B. Nichols et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Social Issues

Second cancers in patients with male breast cancer: a literature review

Tal Grenader et al.

Journal of Cancer Survivorship (2008)